BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25330897)

  • 1. Impact of adjuvant chemotherapy for stage I ovarian carcinoma with intraoperative tumor capsule rupture.
    Shimizu D; Sato N; Sato T; Makino K; Kito M; Shirasawa H; Kumagai J; Terada Y
    J Obstet Gynaecol Res; 2015 Mar; 41(3):432-9. PubMed ID: 25330897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemotherapy for stage i ovarian clear cell carcinoma: is it necessary for stage IA?
    Mizuno M; Kajiyama H; Shibata K; Mizuno K; Yamamuro O; Kawai M; Nakanishi T; Nagasaka T; Kikkawa F
    Int J Gynecol Cancer; 2012 Sep; 22(7):1143-9. PubMed ID: 22801028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival impact of capsule rupture in stage I clear cell carcinoma of the ovary in comparison with other histological types.
    Higashi M; Kajiyama H; Shibata K; Mizuno M; Mizuno K; Hosono S; Kawai M; Nakanishi T; Nagasaka T; Kikkawa F
    Gynecol Oncol; 2011 Dec; 123(3):474-8. PubMed ID: 21955484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy for stage I clear cell carcinoma of the ovary: an analysis of fully staged patients.
    Takada T; Iwase H; Iitsuka C; Nomura H; Sakamoto K; Omatsu K; Takeshima N; Takizawa K
    Int J Gynecol Cancer; 2012 May; 22(4):573-8. PubMed ID: 22398705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical value of surgeons' efforts of preventing intraoperative tumor rupture in stage I clear cell carcinoma of the ovary: A Korean multicenter study.
    Suh DH; Park JY; Lee JY; Kim BG; Lim MC; Kim JW; Bae DS; Park SY; Nam JH; Kim K; No JH; Kim YB
    Gynecol Oncol; 2015 Jun; 137(3):412-7. PubMed ID: 25868967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-stage ovarian clear cell carcinoma: population-based outcomes in British Columbia, Canada, with evidence for a survival benefit as a result of irradiation.
    Hoskins PJ; Le N; Gilks B; Tinker A; Santos J; Wong F; Swenerton KD
    J Clin Oncol; 2012 May; 30(14):1656-62. PubMed ID: 22493415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative Capsule Rupture, Postoperative Chemotherapy, and Survival of Women With Stage I Epithelial Ovarian Cancer.
    Matsuo K; Machida H; Yamagami W; Ebina Y; Kobayashi Y; Tabata T; Kaneuchi M; Nagase S; Enomoto T; Mikami M
    Obstet Gynecol; 2019 Nov; 134(5):1017-1026. PubMed ID: 31599824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of guideline adherence on patient outcomes in early-stage epithelial ovarian cancer.
    Lee JY; Kim TH; Suh DH; Kim JW; Kim HS; Chung HH; Park NH; Song YS; Kang SB
    Eur J Surg Oncol; 2015 Apr; 41(4):585-91. PubMed ID: 25624160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a Gynecologic Oncology Group study.
    Chan JK; Tian C; Fleming GF; Monk BJ; Herzog TJ; Kapp DS; Bell J
    Gynecol Oncol; 2010 Mar; 116(3):301-6. PubMed ID: 19945740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy with carboplatin and taxane compared with single drug carboplatin in early stage epithelial ovarian carcinoma.
    Skírnisdóttir I; Lindborg K; Sorbe B
    Oncol Rep; 2007 Nov; 18(5):1249-56. PubMed ID: 17914581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three versus six cycles of adjuvant platinum-based chemotherapy in early stage clear cell ovarian carcinoma - A multi-institutional cohort.
    Prendergast EN; Holzapfel M; Mueller JJ; Leitao MM; Gunderson CC; Moore KN; Erickson BK; Leath CA; Diaz Moore ES; Cohen JG; Walsh CS
    Gynecol Oncol; 2017 Feb; 144(2):274-278. PubMed ID: 27979319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Less impact of adjuvant chemotherapy for stage I clear cell carcinoma of the ovary: a retrospective Japan Clear Cell Carcinoma Study.
    Takano M; Sugiyama T; Yaegashi N; Sagae S; Kuzuya K; Udagawa Y; Tsuda H; Suzuki M; Kigawa J; Goto T; Tsuda H; Moriya T; Kikuchi Y
    Int J Gynecol Cancer; 2010 Dec; 20(9):1506-10. PubMed ID: 21119366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic analysis of 88 patients with ovarian clear cell carcinoma].
    Ma SK; Zhang HT; Wu LY; Liu LY
    Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):784-8. PubMed ID: 18396695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is adjuvant chemotherapy beneficial for surgical stage I ovarian clear cell carcinoma?
    Hogen L; Brar H; Covens A; Bassiouny D; Bernardini MQ; Gien LT; Ferguson SE; Vicus D
    Gynecol Oncol; 2017 Oct; 147(1):54-60. PubMed ID: 28760368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
    Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S;
    J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved 5-year disease-free survival for FIGO stage I epithelial ovarian cancer patients without tumor rupture during surgery.
    Paulsen T; Kærn J; Tropé C
    Gynecol Oncol; 2011 Jul; 122(1):83-8. PubMed ID: 21435701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
    Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC;
    Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncologic outcome after recurrence in patients with stage I epithelial ovarian cancer: are clear-cell and mucinous histological types a different entities?
    Kajiyama H; Mizuno M; Shibata K; Umezu T; Suzuki S; Yamamoto E; Mitsui H; Sekiya R; Niimi K; Kawai M; Nagasaka T; Kikkawa F
    Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():305-10. PubMed ID: 25203309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma.
    Trimbos JB; Parmar M; Vergote I; Guthrie D; Bolis G; Colombo N; Vermorken JB; Torri V; Mangioni C; Pecorelli S; Lissoni A; Swart AM; ;
    J Natl Cancer Inst; 2003 Jan; 95(2):105-12. PubMed ID: 12529343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of surgical staging in stage I clear cell adenocarcinoma of the ovary.
    Suzuki K; Takakura S; Saito M; Morikawa A; Suzuki J; Takahashi K; Nagata C; Yanaihara N; Tanabe H; Okamoto A
    Int J Gynecol Cancer; 2014 Sep; 24(7):1181-9. PubMed ID: 25010038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.